参考文献/References:
[1]Peng Y,Li Q,Zhang J,et al.Update review of skin adverse events during treatment of lung cancer and colorectal carcinoma with epidermal growth receptor factor inhibitors[J].Biosci Trends,2019,12(6):537-552.[2]Kudo K,Hotta K,Bessho A,et al.Development of a skin rash within the first week and the therapeutic effect in afatinib monotherapy for EGFR-mutant non- small cell lung cancer（NSCLC）: Okayama Lung Cancer Study Group experience[J].Cancer Chemother Pharmacol,2016,77(5):1005-1009.[3]Daver N,Schlenk RF,Russell NH,et al.Targeting FLT3 mutations in AML:review of current knowledge and evidence[J].Leukemia,2019,33(2):299-312.[4]Sun J,Kato I.Gut microbiota,inflammation and colorectal cancer[J].Genes Dis,2016,3(2):130-143．[5]顾慧媛,高欣,钱丽娟,等.益生菌联合早期肠内营养治疗对重症急性胰腺炎患者血清炎性因子、肠黏膜屏障功能的影响[J].海南医学,2017,36(23):3793-3795.[6]Veganzones J,Montero A,Maseda E.New evidence on the use of fosfomycin for bacteremia and infectious endocarditis[J].Rev Esp Quimioter,2019,32(S1):25-29.[7]Grabein B,Graninger W,Rodriguez Bano J,et al.Intravenous fosfomycin-back to the future.Systematic review and meta-analysis of the clinical literature[J].Clin Microbiol Infect,2017,23(6):363-372.[8]张威,姜可伟.肠道菌群在结直肠癌发生发展及治疗中的作用[J].中华胃肠外科杂志,2020,23(5):516-520.[9]Wong SH,zhao L,Zhang X,et al.Gavage of fecal samples from patients with colorectal cancer promotes intestinal carcinogenesis in germ-free and conventional mice[J].Gastroenterology,2017,153(6):1621-1633.[10]Brennan CA,Garrett WS.Gut Microbiota,inflammation,and colorectal cancer[J].Annu Rev Microbiol,2016(70):395-411.[11]Konishi H,Fujiya M,Tanaka H,et al.Probiotiederived ferrichrome inhibits colon cancer progression via JNK-mediated apoptosis[J].Nat Commun,2016(7):12365.[12]张静,闻钰.微生态制剂对小儿血液肿瘤化疗后肠道菌群失调的影响[J].浙江临床医学,2018,20(11):1818-1819.[13]Zhang J,Gu Y,Chen B.Mechanisms of drug resistance in acute myeloid leukemia[J].Onco Targets Ther,2019(12):1937-1945.[14]Dickson RP,Schultz MJ,van der Poll T,et al.Lung microbiota predict clinical outcomes in critically ill patients[J].Am J Respir Crit Care Med,2020,201(5):555-563.[15]Wu D,Lu B,Xue HD,et al.Validation of Modified Determinant-Based Classification of severity for acute pancreatitis in a tertiary teaching hospital[J].Pancreatology,2019,19(2):217-223.[16]Vancamelbeke M,Vermeire S.The intestinal barrier:a fundamental role in health and disease[J].Expert Rev Gastroenterol Hepatol,2017,11(9):821-834．[17]Takam Kamga P,Bassi G,Cassaro A,et al.Notch signalling drives bone marrow stromal cell-mediated chemoresistance in acute myeloid leukemia[J].Oncotarget,2016,7(16):21713-21727.[18]Dos RS,Da CL,Siqueira NP,et al.Review of the mecha- nisms of probotic actions in the prevention of colorectal cancer[J].Nutr Res,2017(37):1-19.[19]Tan SF,Dunton W,Liu X,et al.Acid ceramidase promotes drug resistance in acute myeloid leukemia through NF-kB dependent P-glycoprotein upregulation[J].Lipid Res,2019,60(6):1078-1086.[20]梁运特,黄仲海,廖志远,等.安肠汤对TNBS致溃疡性结肠炎模型大鼠TLR4/NF-κB信号通路及粪钙卫蛋白表达的影响[J].中国药房,2021,32(2):189-194.[21]姚望,张鑫杰,姚庆华.胃肠道恶性肿瘤化疗患者早期肠内营养干预的临床研究[J].中国肿瘤临床,2019,46(15):780-784.[22]Yang Y,Xia Y,Chen H,et al.The effect of perioperative probiotics treatment for colorectal cancer:short-term outcomes of a randomized controlled trial[J].Oncoarget,2016,7(7):8432-8440.[23]Gagniere J,Raisch J,Veziant J,et al.Gut microbiota imbalance and colorectal cancer [J].World J Gastroenterol,2016,22(2):501-518.[24]Lian Q,Xu L,Yan S,et al．Chemotherapy·induced intestinal inflammatory responses are mediated by exosome secretion of doublestrand DNA via AIM2 inflammasome activation[J].Cell Res,2017,27(6):784-800．
相似文献/References:
[1]吴 霞,肖盼盼,谢晓然,等.qRT-PCR法分析复发性SLE患者肠道双歧杆菌、
柔嫩梭菌数量的变化[J].医学信息,2018,31(05):65.[doi:10.3969/j.issn.1006-1959.2018.05.022]
WU Xia,XIAO Pan-pan,XIE Xiao-ran,et al.Analysis of the Changes of Intestinal Bifidobacterium and Clostridium Tenella in Patients with Recurrent SLE by qRT-PCR[J].Medical Information,2018,31(06):65.[doi:10.3969/j.issn.1006-1959.2018.05.022]
[2]石 磊,孙新增,李宝山,等.Ⅱ、Ⅲ期结肠癌患者辅助化疗XELOX方案、FOLFOX方案的临床疗效、不良反应及生活质量对比[J].医学信息,2018,31(13):68.[doi:10.3969/j.issn.1006-1959.2018.13.020]
SHI Lei,SUN Xin-zeng,LI Bao-shan,et al.Clinical Efficacy,Adverse Reactions and Quality of Life of Adjuvant Chemotherapy XELOX and FOLFOX in Patients with Stage II and III Colon Cancer[J].Medical Information,2018,31(06):68.[doi:10.3969/j.issn.1006-1959.2018.13.020]
[3]陈明丽.栀子大黄汤加减联合双歧杆菌三联活菌肠溶胶囊、蓝光照射治疗新生儿病理性黄疸的效果[J].医学信息,2021,34(24):154.[doi:10.3969/j.issn.1006-1959.2021.24.040]
CHEN Ming-li.Effect of Modified Zhizi Dahuang Decoction Combined with Bifidobacterium Triple Viable Enteric-coated Capsules and Blue Light Irradiation on Neonatal Pathological Jaundice[J].Medical Information,2021,34(06):154.[doi:10.3969/j.issn.1006-1959.2021.24.040]